The coronavirus crisis in South Africa is far from over despite falling case numbers in recent weeks. The virus has claimed\u00a0more than\u00a0of\u00a050,000\u00a0lives, and many health experts predict a\u00a0devastating third wave. Complicating matters is a\u00a0new coronavirus mutation known as n501, which threatens to\u00a0upend\u00a0South Africa\u2019s vaccination\u00a0plans.<\/p>\n
Unprecedented scientific collaboration has expedited the development of the new vaccine candidates, but patents protecting the bottom lines of the pharmaceutical companies have hampered efforts to manufacture vaccines at scale. Meanwhile, the United States and Western Europe have\u00a0hoarded limited\u00a0supplies\u00a0through bilateral negotiations with Big Pharma. Developing nations in the Global South have been left\u00a0behind.<\/p>\n
The post The Global South Faces A ‘Vaccine Apartheid’<\/a> appeared first on PopularResistance.Org<\/a>.<\/p>\n\n